Step by step with Kristina Kristina reviews your history, BMI, labs, and goals to confirm GLP-1 therapy is right for you
The article says the decision belongs with the endocrinologist or primary care provider who knows the person's full immune and thyroid history, and that a candidate needs a separate clinical indication such as obesity, type 2 diabetes or cardiovascular risk plus stable thyroid disease on levothyroxine
These are real barriers, and obesity is now recognized as a complex chronic disease that must be addressed on an individualized basis
Taking into account the penetration of various peripheral immune cells into brain tissues, especially into the areas surrounding the infarction site, it is important that GLP-1RAs can not only contribute to the polarization of microglia M2 both directly and indirectly, but also modulate the number and function of subtypes of T cells, including CD4, CD8 and regulatory T cells [25]
162 Kwon et al